Does real-time glucose tracking before surgery cut complications? a massive trial puts it to the test.

NCT ID NCT06331923

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial tests whether using a continuous glucose monitor (CGM) before and after major surgery can reduce complications in adults with diabetes or impaired glucose tolerance. Participants wear the device for at least 6 hours before surgery and up to 7 days after, while a comparison group receives standard glucose checks. The goal is to see if CGM leads to fewer and less severe complications within 30 days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
continuous glucose monitoring (CGM) device
What this could lead to
If effective, CGM could become a standard tool to reduce post-surgical complications in people with diabetes.
What could go wrong
This is a large pragmatic trial, but the benefit of CGM over conventional monitoring in surgical settings is not yet proven, and device calibration or patient adherence may affect results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMPREHENSIVE COMPLICATION INDEX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Tsinghua Changgung Hospital

    Beijing, Beijing Municipality, 102218, China

  • Department of Anesthesiology, Emergency General Hospital

    Beijing, China

  • Department of Anesthesiology, Peking University International Hospital

    Beijing, China

  • Department of Anesthesiology, Peking University Shougang Hospital

    Beijing, China

  • Department of Anesthesiology, Yueyang Central Hospital

    Hunan, China

  • Department of Endocrinology and Metabolism, Fuzhou First General Hospital Affiliated with Fujian Medical University

    Fuzhou, China

  • Department of Endocrinology and Metabolism, The Second Hospital of Shanxi Medical University

    Shanxi, China

  • Department of Endocrinology, Jilin Chemical Hospital

    Jilin City, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.